“…Exogenously provided H2S, either in gas form or via donor molecules, increases lifespan in model organisms (Miller and Roth, 2007), prevents multi-tissue ischemic-reperfusion injury (Elrod et al, 2007;Hine et al, 2015), improves cardiovascular health Yang et al, 2008), and is recognized as a potential therapeutic agent against aging-associated diseases (Zhang et al, 2013). Conversely, deficiencies in endogenous H2S levels or production correlate with and/or are causative of hypertension (Yang et al, 2008), colitis (Flannigan et al, 2014), neurodegeneration (Sbodio et al, 2016), and glioma growth (Takano et al, 2014) while H2S levels in humans are reported to decline during aging, particularly those suffering from COPD (Chen et al, 2005;Perridon et al, 2016). Thus, the field of H2S in biology, physiology, and medicine has blossomed (Wallace and Wang, 2015;Wang, 2012), with endogenous H2S serving as a therapeutic target and the third functional gasotransmitter alongside carbon monoxide and nitric oxide (Paul and Snyder, 2018).…”